Alagase, Leonardo N.
HRN: 20-27-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/03/2024
12/09/2024
IV
2.25gm
Q8
Dm Foot Right
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes